EuroEyes International Eye Clinic Limited

Equities

1846

KYG3224D1088

Healthcare Facilities & Services

Delayed Hong Kong S.E. 01:00:00 2024-04-25 am EDT 5-day change 1st Jan Change
4.8 HKD 0.00% Intraday chart for EuroEyes International Eye Clinic Limited +2.35% -7.87%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
EuroEyes International Logs 6% Growth in Q1 Eye Surgeries MT
EuroEyes International Eye Clinic Limited Proposes Final Ordinary Dividend for the Year Ended 31 December 2023, Payable on 28 June 2024 CI
EuroEyes International Eye Clinic Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
EuroEyes International Forecasts Boost in 2023 Profit MT
Euroeyes International Eye Clinic Limited Provides Preliminary Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2023 CI
EuroEyes Reports 14% Increase In Q4 Surgeries MT
EuroEyes International Eye Clinic Limited Announces Change of Address of the Principal Place of Business in Hong Kong, Effective 11 November 2023 CI
EuroEyes International Boosts Q3 Eye Surgeries by 17% MT
EuroEyes International Eye Clinic Limited Announces Interim Dividend for the Six Months Ended 30 June 2023, Payable on 28 September 2023 CI
EuroEyes International Eye Clinic Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
EuroEyes International Unit Signs Deal to Buy Germany-based Eye Clinic MT
EuroEyes International Eye Clinic to Boost H1 Profit MT
EuroEyes International Eye Clinic Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023 CI
Euroeyes International Eye Clinic Limited Proposes Final Dividend for the Year Ended 31 December 2022, Payable on 21 June 2023 CI
EuroEyes International Eye Clinic Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
EuroEyes International Eye Clinic to Shrink Profit in 2022 MT
Euroeyes International Eye Clinic Limited Provides Earnings Outlook for the Year Ended 31 December 2022 CI
Euroeyes International Eye Clinic Limited Announces Resignation of Ralf-Christian Lerche as an Executive Director CI
EuroEyes International Eye Clinic Limited(SEHK:1846) dropped from S&P Global BMI Index CI
Transcript : EuroEyes International Eye Clinic Limited, H1 2022 Earnings Call, Aug 25, 2022
EuroEyes International Eye Clinic's H1 Profit Falls 33.7%; Shares Climbs 4% MT
EuroEyes International Eye Clinic Limited Reports Earnings Results for the Half Year Ended June 30, 2022 CI
EuroEyes International Eye Clinic Expects Fall in H1 Net Profit MT
EuroEyes International Eye Clinic's H1 Number of Eye Surgeries Decline MT
Euroeyes International Eye Clinic Limited Appoints Dan Zoltan Reinstein as Executive Director CI
Chart EuroEyes International Eye Clinic Limited
More charts
Euroeyes International Eye Clinic Ltd is a Germany-based company engaged in the optical industry. The Company provides various services for vision correction, such as refractive laser surgery, phakic lens surgery and lens exchange surgery. The Company operates in Germany, Denmark and China.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
4.8 HKD
Average target price
7.26 HKD
Spread / Average Target
+51.25%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 1846 Stock
  4. News EuroEyes International Eye Clinic Limited
  5. EuroEyes International Eye Clinic Expects Fall in H1 Net Profit